Overview
Samson has over 12 years of experience in advising on capital market and corporate transactions, including Hong Kong SAR initial public offerings (IPO), pre-IPO investment, post-IPO equity financing, M&A transactions and general corporate matters. He focuses on advising new economy issuers and financial institutions in the technology and healthcare sectors on new economy listings in Hong Kong, including the listings of pre-revenue biotech companies under Chapter 18A, and issuers with weighted voting rights (WVR) and VIE structures, as well as in secondary listings and spin-off listings. Samson has consistently been recognised as a Notable Practitioner in China equity capital markets by IFLR over the past five years (2019-2024).
Work highlights
Samson’s experience highlights include advising on:
- Hong Kong IPOs or listings by way of introduction including Chenqi Technology (also known as Ruqi Mobility), Bilibili, JD.com, JF Wealth, Kanzhun (also known as BOSS Zhipin), Ping An OneConnect Financial Technology, XD Inc., Weimob, iDreamSky Technology, China Literature, Ping An Healthcare and Technology (also known as Ping An Good Doctor), SciClone Pharmaceuticals, Sirnaomics, Lepu Biopharma, Harbour BioMed, Shanghai Chicmax Cosmetic, Bank of Jiujiang, CIMC Vehicles, Inner Mongolia Energy Engineering, China Kepei Education Group and Virscend Education.*
- M&A transactions in the TMT, healthcare and consumer sectors including SciClone Pharmaceuticals on its privatisation by GL Capital, Tencent on its HK$3.3bn subscription in Meituan, China Literature on the RMB 15.5bn acquisition of New Classics Media, Actis on its disposal of investment in Jiashili Group and Red Star Macalline on the sale of 29.95% equity interests by the controlling shareholder to Xiamen C&D Inc.*
*Denotes experience from previous firms
Education and qualifications
Samson holds an Executive Master of Laws from Columbia Law School, New York and an undergraduate degree in laws from the Chinese University of Hong Kong.
He is admitted in Hong Kong SAR and UK (England & Wales) and is fluent in English, Mandarin and Cantonese.
